RPH — Ropharma SA Cashflow Statement
0.000.00%
Last trade - 00:00- RON143.15m
- RON285.94m
- RON1.54bn
Annual cashflow statement for Ropharma SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
R2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.7 | 7.49 | 11.7 | 5.38 | 6.85 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 8.37 | 1.24 | 8.56 | 20.5 | 21.2 |
| Accounting Change | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.1 | -2.38 | -6 | -10.7 | 12.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 38.7 | 29.9 | 40.5 | 43.2 | 72.8 |
| Capital Expenditures | -18.6 | -18.1 | -16.2 | -18.7 | -25 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 6.3 | 3.3 | 1.64 | 3.81 | 5.38 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.3 | -14.8 | -14.5 | -14.9 | -19.6 |
| Financing Cash Flow Items | -3.22 | -1.07 | -4.88 | -5.92 | -4.98 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -30.4 | -10.4 | -24.9 | -24.8 | -15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4 | 4.77 | 1.09 | 3.39 | 38.2 |